Study number 8529-369
Dates
Apr 18 2024-May 17 2024
Location
Daytona Beach, Florida
Age
18-50
Gender
Men and Women
Compensation
$4,534
Group
1b OR 1c
The investigational drug in this research study is being developed for the treatment of a type of peripheral nerve disease called Chronic Inflammatory Demyelinating Polyneuropathy, a disorder that involves progressive weakness and reduced senses in the arms and legs.
The purposes of this study are to evaluate the safety, tolerability, how much of the study drug gets into the bloodstream and how long the body takes to clear it. You will receive a single dose of the study drug or a placebo (inactive substance) administered as up to 4 injections under the skin surface of your abdomen.
Fortrea Daytona Beach, FL is recruiting for:
- Healthy Non-Smoking Men and Women, Age 18-50
- Body Mass Index between 18-32
- Study involves 1 stay of 5 nights & 5 follow-up visits
- Compensation up to $4,534 may be provided for time and participation
- Refer a friend to receive $300 per qualified referral
Call Now to Schedule Your Screening Appointment.
Group 1b:
Check-in: Apr 18
Check-out: Apr 23
Follow up Visits: Apr 26, 29, May 3, 10, 17
OR
Group 1c:
Check-in: Apr 21
Check-out: Apr 26
Follow up Visits: Apr 29, May 2, 6, 13, 20